Identification of suspected fatal adverse drug reactions by paediatricians: A UK surveillance study

Archives of Disease in Childhood

Volumn 93, Issue 7, 2008, Pages 609-611

  Cheng, K ^a   Masters, S ^a   Stephenson, T ^b,f   Cooke, R ^c   Ferner, R ^d   Ashworth, M ^e   Nunn, A J ^e  

^a MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^d CITY HOSPITAL   (United Kingdom)

^e ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^f Academic Division of Child Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; ENALAPRIL; FENTANYL; ISOFLURANE; PNEUMOCOCCUS VACCINE; PROPOFOL; SUXAMETHONIUM; THYROXINE; VALPROIC ACID; ZIDOVUDINE; DRUG;

ACUTE PANCREATITIS; ADOLESCENT; ADVERSE DRUG REACTION; ANEMIA; ARTICLE; BRADYCARDIA; CARDIOPULMONARY INSUFFICIENCY; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONGENITAL HYPOTHYROIDISM; CONSENSUS; DEATH; DROWSINESS; DRUG FATALITY; DRUG SURVEILLANCE PROGRAM; ERYTHROPHAGOCYTOSIS; FEEDING DISORDER; HEART ARREST; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFANT; IRELAND; IRRITABILITY; LIVER FAILURE; NEWBORN; PEDIATRICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RECOMMENDED DRUG DOSE; SEIZURE; SIDE EFFECT; UNITED KINGDOM; VOMITING; CASE REPORT; CHILD; DRUG THERAPY; HEALTH SURVEY; MORTALITY;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; DRUG THERAPY; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; IRELAND; PHARMACEUTICAL PREPARATIONS; POPULATION SURVEILLANCE;

EID: 48949119144     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.107789     Document Type: Article

References (18)

1. Turner S, Longworth A, Nunn AJ, et al. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998;316:343-5.
2. Conroy S, Choonara I. Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000;320:79-82.
3. Conroy S, Mclntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F142-5.
4. Inman WHW. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. BMJ 1977;1:1500- 5.
5. Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off label drugs on paediatric wards: a prospective study. Acta Paediatr 1999;88:965-8.
6. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-1205.
7. Moore TJ, Weiss SR, Kaplan S. et al. Reported adverse drug events in infants and children under 2 years of age. Pediatrics 2002;110:e53.
8. British Paediatric Surveillance Unit. Annual report 2002-2003. London: Royal College of Paediatrics and Child Health. 2003.
9. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet 2000;356:1255-9.
10. Royal College of Paediatrics and Child Health and the Neonatal and Paediatric Pharmacists Group. Medicines for children. London: Royal College of Paediatrics and Child Health, 1999.
11. Summary of Product Characteristics: Innovace, Merck Sharp and Dohme.
12. Davis DM. Textbook of adverse drug reactions. 4th edn. Oxford: Oxford University Press, 1991.
13. Sanchez PJ, Laptook AR, Fisher L, et al. Apnea after immunisation. J Pediatr 1997;130:746-51.
14. Botham SJ, Isaacs D, Henderson-Smart DJ. Incidence of apnoea and bradycardia in preterm infants following DTPw and Hib immunization: a prospective study. J Paediatr Child Health 1997;33:418-21.
15. British National Formulary. London: Pharmaceutical Press, 2003.
16. Glaxo Smith Kline. Summary of product characteristics: Retrovir. Uxbridge: Glaxo Smith Kline.
17. Office for National Statistics: unpublished data. If this is still unpublished that it will need to be noted in the text as unpublished. If it has since been published please provide the name of the report, date, author, publisher and location and perhaps a URL.
18. Mittmann N, Knowles SR, Gomez M, et al. Evaluation of the extent of underreporting of serious adverse drug reactions. The case of toxic epidermal necrolysis. Drug Safety 2004;27:477-7.